Market Competition

Keen market competition can be observed both in the fields of drugs and automobiles.Paxlovid of Pfizer (PFE) is said it can cut the death rate of Covid-19 by 89%, but must be treated on the first 3 days, while Molunpiravir of Merck (MRK) can only cut 50%. Thus the price of PFE jumped up a gap, MRK jumped down a gap, and Remdesivir of Gilead (GILD) also lowered.

Market Competition

Keen market competition can be observed both in the fields of drugs and automobiles.

Paxlovid of Pfizer (PFE) is said it can cut the death rate of Covid-19 by 89%, but must be treated on the first 3 days, while Molunpiravir of Merck (MRK) can only cut 50%. Thus the price of PFE jumped up a gap, MRK jumped down a gap, and Remdesivir of Gilead (GILD) also lowered.

You are not authorized to view report. Please Login or visit Membership page.

Comments are closed.